Bill Gates funds Global firm pushing “mining” of DNA data through COVID tests – aiming for huge DNA database of millions of people. BGI Genomics – the Genomics company linked to Chinese Communist Party that U.S. officials have called the “mining” of Americans’ DNA – has, according to The National Pulse worked intensively with the Bill & Melinda Gates Foundation. Read here.
The company was recently criticised after a video on 60 Minutes Show about the company’s use of COVID-19 tests to “collect, store and exploit biometric information” on American citizens, according to a former US intelligence official. Even more, a recent Article from Reuters – shows the company’s connection with the Chinese Communist Party and the military. Read here.
In addition to the Obama administration, which enabled the company to gain a foothold in the U.S., the Bill & Melinda Gates Foundation played a critical role in BGI’s American expansion.
In September 2012, the Microsoft founder’s foundation signed a “Memorandum of Understanding” (MOU) to collaborate on global health and agricultural development with the aim of achieving common goals in the areas of health and agricultural development.
Co-founder of the BGI
The BGI co-founder praised the agreement and celebrated the upcoming “scientific breakthroughs in human, plant and animal genomics.” He also revealed that the collaboration would focus on genome sequencing – the very activity that the 60 Minutes piece called a threat to national security.
“We have contributed to the Human Genome Project, as well as the sequencing of the genomes of many plant and animal species and human diseases, including the initial sequencing of the rice genome, as well as our involvement in the Rice 10,000 Genomes Project, the 1,000 Plant and Animal Genomes Project, the International 1,000 Genomes Project, the 1,000 Rare Diseases Project, the International Cancer Genome Project, Autism Genome 10K, and more. BGI looks forward to working with the Bill & Melinda Gates Foundation in this important collaboration to apply genomics research to benefit global human health.”
The memorandum precedes Gates’ 2010 visit to BGI headquarters in China, where he witnessed the company’s genetic sequencing, according to the Financial Times:
“In 2010, Bill Gates visited a nondescript building in an industrial park on the outskirts of Shenzhen, China. With an array of high-tech machines humming inside the building, the place could easily be mistaken for an anonymous database. But Mr. Gates and Ray Yip, head of the Gates Foundation’s China operation, saw something different that day.
On a tour of BGI’s headquarters, the two men were amazed by the ambition of the scientists working at the biotech company. Inside, more than 150 state-of-the-art gene sequencing machines analyzed the equivalent of thousands of human genomes per day. The company is working toward the goal of building a vast library based on the DNA of many millions of people. BGI executives see this not as an end point, but as a springboard for new drug discovery, advanced genetic research, and public health policy change. Yip praised the venture as “out-of-the-box,” calling it “open” and “liberal.”
“We were amazed. We never thought we would find such an unconventional approach. They are in their own league – open and liberal. Most people see them as just a DNA analysis service provider. Yet it’s the database they’re building that will make them formidable.
Communist Party of China
The Gates Foundation has funded BGI genome sequencing projects alongside Chinese Communist Party institutions such as the Ministry of Science and Technology and the Academy of Agricultural Sciences.
Similarly, Dr. Tadataka Yamada, former president of the Bill & Melinda Gates Foundation’s Global Health Program, serves as chair of BGI’s Scientific Advisory Board.
And in 2016, BGI opened an office in Washington, the home state of Microsoft and the Bill & Melinda Gates Foundation. BGI’s ties to Washington also appear to have influenced the company’s decision to target the state with its COVID-19 test kits, which are part of the company’s plan to “mine“.
“Early last March, Washington state saw the first major coronavirus outbreak in the US. As COVID rates and the need for testing skyrocketed, BGI Group, the world’s largest biotech company – a global giant based in China – approached Washington state with an enticing offer. In a strikingly personal letter to the governor, BGI proposed to build and operate state-of-the-art COVID testing labs,” summarizes the broadcast 60 Minutes.
But officials rejected the offer at the request of the Office of the Director of National Intelligence because of the BGI’s relationship with the Chinese government.